Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Zheng, X; Chang, RL; Cui, XX; Kelly, KA; Shih, WCJ; Lin, Y; Strair, R; Suh, J; Han, ZT; Rabson, A; Conney, AH
   Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1 alpha,25-dihydroxyvitamin D-3, and sodium butyrate on differentiation in HL-60 cells
   ONCOLOGY RESEARCH
   
   X. Zheng et al., "Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1 alpha,25-dihydroxyvitamin D-3, and sodium butyrate on differentiation in HL-60 cells", ONCOL RES, 12(9-10), 2001, pp. 419-427
2. Zhang, TD; Chen, GQ; Wang, ZG; Wang, ZY; Chen, SJ; Chen, Z
   Arsenic trioxide, a therapeutic agent for APL
   ONCOGENE
   
   T.D. Zhang et al., "Arsenic trioxide, a therapeutic agent for APL", ONCOGENE, 20(49), 2001, pp. 7146-7153
3. Zhu, J; Lallemand-Breitenbach, V; de The, H
   Pathways of retinoic acid- or arsenic trioxide-induced PML/RAR alpha catabolism, role of oncogene degradation in disease remission
   ONCOGENE
   
   J. Zhu et al., "Pathways of retinoic acid- or arsenic trioxide-induced PML/RAR alpha catabolism, role of oncogene degradation in disease remission", ONCOGENE, 20(49), 2001, pp. 7257-7265
4. Wang, TS; Hsu, TY; Chung, CH; Wang, ASS; Bau, DT; Jan, KY
   Arsenite induces oxidative DNA adducts and DNA-protein cross-links in mammalian cells
   FREE RADICAL BIOLOGY AND MEDICINE
   
   T.S. Wang et al., "Arsenite induces oxidative DNA adducts and DNA-protein cross-links in mammalian cells", FREE RAD B, 31(3), 2001, pp. 321-330
5. Ishizuka, S; Miura, D; Ozono, K; Saito, M; Eguchi, H; Chokki, M; Norman, AW
   (23S)- and (23R)-25-dehydro-1 alpha-hydroxyvitamin D-3-26,23-lactone function as antagonists of vitamin D receptor-mediated genomic actions of 1 alpha,25-dihydroxyvitamin D-3
   STEROIDS
   
   S. Ishizuka et al., "(23S)- and (23R)-25-dehydro-1 alpha-hydroxyvitamin D-3-26,23-lactone function as antagonists of vitamin D receptor-mediated genomic actions of 1 alpha,25-dihydroxyvitamin D-3", STEROIDS, 66(3-5), 2001, pp. 227-237
6. Bode, A; Dong, ZG
   Apoptosis induction by arsenic: mechanisms of action and possible clinicalapplications for treating therapy-resistant cancers
   DRUG RESISTANCE UPDATES
   
   A. Bode e Z.G. Dong, "Apoptosis induction by arsenic: mechanisms of action and possible clinicalapplications for treating therapy-resistant cancers", DRUG RESIST, 3(1), 2000, pp. 21-29
7. Gianni, M; Ponzanelli, I; Mologni, L; Reichert, U; Rambaldi, A; Terao, M; Garattini, E
   Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases
   CELL DEATH AND DIFFERENTIATION
   
   M. Gianni et al., "Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases", CELL DEAT D, 7(5), 2000, pp. 447-460
8. Tenno, T; Botling, J; Oberg, F; Jossan, S; Nilsson, K; Siegbahn, A
   The role of RAR and RXR activation in retinoid-induced tissue factor suppression
   LEUKEMIA
   
   T. Tenno et al., "The role of RAR and RXR activation in retinoid-induced tissue factor suppression", LEUKEMIA, 14(6), 2000, pp. 1105-1111
9. Cai, X; Shen, YL; Zhu, Q; Jia, PM; Yu, Y; Zhou, L; Huang, Y; Zhang, JW; Xiong, SM; Chen, SJ; Wang, ZY; Chen, Z; Chen, GQ
   Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia
   LEUKEMIA
   
   X. Cai et al., "Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia", LEUKEMIA, 14(2), 2000, pp. 262-270
10. Daniel, PT
    Dissecting the pathways to death
    LEUKEMIA
    
    P.T. Daniel, "Dissecting the pathways to death", LEUKEMIA, 14(12), 2000, pp. 2035-2044
11. Kitamura, K; Minami, Y; Yamamoto, K; Akao, Y; Kiyoi, H; Saito, H; Naoe, T
    Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis
    LEUKEMIA
    
    K. Kitamura et al., "Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis", LEUKEMIA, 14(10), 2000, pp. 1743-1750
12. Rego, EM; He, LZ; Warrell, RP; Wang, ZG; Pandolfi, PP
    Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    E.M. Rego et al., "Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins", P NAS US, 97(18), 2000, pp. 10173-10178
13. Kitamura, K; Hoshi, S; Koike, M; Kiyoi, H; Saito, H; Naoe, T
    Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid
    BRITISH JOURNAL OF HAEMATOLOGY
    
    K. Kitamura et al., "Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid", BR J HAEM, 108(4), 2000, pp. 696-702
14. Chelbi-Alix, MK; Pelicano, L
    Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells
    LEUKEMIA
    
    M.K. Chelbi-Alix e L. Pelicano, "Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells", LEUKEMIA, 13(8), 1999, pp. 1167-1174
15. Song, XD; Norman, AW
    Bryostatin-1 and 1 alpha,25-dihydroxyvitamin D-3 synergistically stimulatethe differentiation of NB4 acute promyelocytic leukemia cells
    LEUKEMIA
    
    X.D. Song e A.W. Norman, "Bryostatin-1 and 1 alpha,25-dihydroxyvitamin D-3 synergistically stimulatethe differentiation of NB4 acute promyelocytic leukemia cells", LEUKEMIA, 13(2), 1999, pp. 275-281
16. Duitsman, PK; Barua, AB; Becker, B; Olson, JA
    Effects of epoxycarotenoids, beta-carotene, and retinoic acid on the differentiation and viability of the leukemia cell line NB4 in vitro
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
    
    P.K. Duitsman et al., "Effects of epoxycarotenoids, beta-carotene, and retinoic acid on the differentiation and viability of the leukemia cell line NB4 in vitro", INT J VIT N, 69(5), 1999, pp. 303-308
17. Benoit, G; Altucci, L; Flexor, M; Ruchaud, S; Lillehaug, J; Raffelsberger, W; Gronemeyer, H; Lanotte, M
    RAR-independent RXR signaling induces t(15;17) leukemia cell maturation
    EMBO JOURNAL
    
    G. Benoit et al., "RAR-independent RXR signaling induces t(15;17) leukemia cell maturation", EMBO J, 18(24), 1999, pp. 7011-7018
18. Zhu, J; Gianni, M; Kopf, E; Honore, N; Chelbi-Alix, M; Koken, M; Quignon, F; Rochette-Egly, C; de The, H
    Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RAR alpha) and oncogenic RAR alpha fusion proteins
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    J. Zhu et al., "Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RAR alpha) and oncogenic RAR alpha fusion proteins", P NAS US, 96(26), 1999, pp. 14807-14812
19. Touhami, M; Bourge, JF; Legrand, C
    Increased adhesion of the promyelocytic leukaemia cell line, NB4, to fibronectin and thrombospondin upon all-trans-retinoic acid treatment
    BRITISH JOURNAL OF HAEMATOLOGY
    
    M. Touhami et al., "Increased adhesion of the promyelocytic leukaemia cell line, NB4, to fibronectin and thrombospondin upon all-trans-retinoic acid treatment", BR J HAEM, 104(4), 1999, pp. 706-714
20. Naoe, T; Kitamura, K
    Relationship between degradation of PML-RAR alpha and differentiation
    BLOOD
    
    T. Naoe e K. Kitamura, "Relationship between degradation of PML-RAR alpha and differentiation", BLOOD, 94(4), 1999, pp. 1478-1478
21. Mologni, L; Ponzanelli, I; Bresciani, F; Sardiello, G; Bergamaschi, D; Gianni, M; Reichert, U; Rambaldi, A; Terao, M; Garattini, E
    The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalenecarboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases
    BLOOD
    
    L. Mologni et al., "The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalenecarboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases", BLOOD, 93(3), 1999, pp. 1045-1061
22. QUENECHDU N; RUCHAUD S; KHELEF N; GUISO N; LANOTTE M
    A SUSTAINED INCREASE IN THE ENDOGENOUS LEVEL OF CAMP REDUCES THE RETINOID CONCENTRATION REQUIRED FOR APL CELL MATURATION TO NEAR PHYSIOLOGICAL LEVELS
    Leukemia
    
    N. Quenechdu et al., "A SUSTAINED INCREASE IN THE ENDOGENOUS LEVEL OF CAMP REDUCES THE RETINOID CONCENTRATION REQUIRED FOR APL CELL MATURATION TO NEAR PHYSIOLOGICAL LEVELS", Leukemia, 12(11), 1998, pp. 1829-1833
23. SONG XD; NORMAN AW
    1-ALPHA,25-DIHYDROXYVITAMIN D-3 AND PHORBOL ESTER MEDIATE THE EXPRESSION OF ALKALINE-PHOSPHATASE IN NB4 ACUTE PROMYELOCYTIC LEUKEMIA-CELLS
    Leukemia research
    
    X.D. Song e A.W. Norman, "1-ALPHA,25-DIHYDROXYVITAMIN D-3 AND PHORBOL ESTER MEDIATE THE EXPRESSION OF ALKALINE-PHOSPHATASE IN NB4 ACUTE PROMYELOCYTIC LEUKEMIA-CELLS", Leukemia research, 22(1), 1998, pp. 69-76
24. WELCH H; MARIDONNEAUPARINI I
    LYN AND FGR ARE ACTIVATED IN DISTINCT MEMBRANE-FRACTIONS OF HUMAN GRANULOCYTIC CELLS
    Oncogene
    
    H. Welch e I. Maridonneauparini, "LYN AND FGR ARE ACTIVATED IN DISTINCT MEMBRANE-FRACTIONS OF HUMAN GRANULOCYTIC CELLS", Oncogene, 15(17), 1997, pp. 2021-2029
25. NDIAYE EN; VAISSIERE C; GONZALEZCHRISTEN J; GREGOIRE C; LECABEC V; MARIDONNEAUPARINI I
    EXPRESSION OF NADPH OXIDASE IS INDUCED BY ALL-TRANS-RETINOIC ACID BUTNOT BY PHORBOL-MYRISTATE ACETATE AND 1,25-DIHYDROXYVITAMIN-D3 IN THE HUMAN PROMYELOCYTIC CELL-LINE NB4
    Leukemia
    
    E.N. Ndiaye et al., "EXPRESSION OF NADPH OXIDASE IS INDUCED BY ALL-TRANS-RETINOIC ACID BUTNOT BY PHORBOL-MYRISTATE ACETATE AND 1,25-DIHYDROXYVITAMIN-D3 IN THE HUMAN PROMYELOCYTIC CELL-LINE NB4", Leukemia, 11(12), 1997, pp. 2131-2136
26. QUIGNON F; CHEN Z; DETHE H
    RETINOIC ACID AND ARSENIC - TOWARDS ONCOGENE-TARGETED TREATMENTS OF ACUTE PROMYELOCYTIC LEUKEMIA
    Biochimica et biophysica acta, CR. Reviews on cancer
    
    F. Quignon et al., "RETINOIC ACID AND ARSENIC - TOWARDS ONCOGENE-TARGETED TREATMENTS OF ACUTE PROMYELOCYTIC LEUKEMIA", Biochimica et biophysica acta, CR. Reviews on cancer, 1333(3), 1997, pp. 53-61
27. NIITSU N; YAMAMOTOYAMAGUCHI Y; KANATANI Y; SHUTO S; MATSUDA A; UMEDA M; HONMA Y
    NEPLANOCIN-A, A POTENT INHIBITOR OF S-ADENOSYLHOMOCYSTEINE HYDROLASE,POTENTIATES GRANULOCYTIC DIFFERENTIATION OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS INDUCED BY ALL-TRANS-RETINOIC ACID
    Experimental hematology
    
    N. Niitsu et al., "NEPLANOCIN-A, A POTENT INHIBITOR OF S-ADENOSYLHOMOCYSTEINE HYDROLASE,POTENTIATES GRANULOCYTIC DIFFERENTIATION OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS INDUCED BY ALL-TRANS-RETINOIC ACID", Experimental hematology, 25(12), 1997, pp. 1296-1303
28. NASONBURCHENAL K; MAERZ W; ALBANELL J; ALLOPENNA J; MARTIN P; MOORE MAS; DMITROVSKY E
    COMMON DEFECTS OF DIFFERENT RETINOIC ACID-RESISTANT PROMYELOCYTIC LEUKEMIA-CELLS ARE PERSISTENT TELOMERASE ACTIVITY AND NUCLEAR-BODY DISORGANIZATION
    Differentiation
    
    K. Nasonburchenal et al., "COMMON DEFECTS OF DIFFERENT RETINOIC ACID-RESISTANT PROMYELOCYTIC LEUKEMIA-CELLS ARE PERSISTENT TELOMERASE ACTIVITY AND NUCLEAR-BODY DISORGANIZATION", Differentiation, 61(5), 1997, pp. 321-331
29. BOCCHIA M; XU Q; WESLEY U; XU Y; KORONTSVIT T; LOGANZO F; ALBINO AP; SCHEINBERG DA
    MODULATION OF P53, WAF1 P21 AND BCL-2 EXPRESSION DURING RETINOIC ACID-INDUCED DIFFERENTIATION OF NB4 PROMYELOCYTIC CELLS/
    Leukemia research
    
    M. Bocchia et al., "MODULATION OF P53, WAF1 P21 AND BCL-2 EXPRESSION DURING RETINOIC ACID-INDUCED DIFFERENTIATION OF NB4 PROMYELOCYTIC CELLS/", Leukemia research, 21(5), 1997, pp. 439-447
30. CHIH DY; CHUMAKOV AM; PARK DJ; SILLA AG; KOEFFLER HP
    MODULATION OF MESSENGER-RNA EXPRESSION OF A NOVEL HUMAN MYELOID-SELECTIVE CCAAT ENHANCER BINDING-PROTEIN GENE (C/EBP-EPSILON)/
    Blood
    
    D.Y. Chih et al., "MODULATION OF MESSENGER-RNA EXPRESSION OF A NOVEL HUMAN MYELOID-SELECTIVE CCAAT ENHANCER BINDING-PROTEIN GENE (C/EBP-EPSILON)/", Blood, 90(8), 1997, pp. 2987-2994